Skip to main navigation Skip to search Skip to main content

Clinical, Economic, and Humanistic Impact of Short-Bowel Syndrome/Chronic Intestinal Failure in Portugal (PARENTERAL Study)

  • Raul Silva
  • , Paula Guerra
  • , Anabela Rocha
  • , Miguel Correia
  • , Ricardo Ferreira
  • , Jorge Fonseca
  • , Eduardo Lima
  • , António Oliveira
  • , Marta Vargas Gomes
  • , Diogo Ramos
  • , Valeska Andreozzi
  • , Marisa D. Santos

Research output: Contribution to journalArticlepeer-review

16 Citations (Scopus)

Abstract

Introduction: This study aimed to assess the clinical, economic, and humanistic impact of short-bowel syndrome/chronic intestinal failure (SBS/CIF) in Portugal. Methods: This is a retrospective multicenter cohort chart review study, with a cross-sectional component for quality-of-life (QoL) evaluation. Inclusion criteria comprised patients with SBS/CIF, aged ≥1 year, with stable parenteral nutrition (PN). Data collection included patient chart review over a 12-month period and patient/caregiver self-report and SF-36/PedsQL™ questionnaires. Main endpoints comprised clinical and PN characterization, healthcare resource use (HRU), direct costs, and patient QoL. Results: Thirty-one patients were included (11 adults and 20 children). Patients' mean age (standard deviation [SD]) was 57.9 (14.3) years in adults and 7.5 (5.0) years in children, with a mean time since diagnosis of 10.2 (5.9) and 6.6 (4.2) years, respectively. PN was administered for a mean of 5.2 and 6.6 days/week in adults and children, respectively; home PN occurred in 81.8% of adults and 90.0% of children for a mean of 9.6 and 10.8 months/year, respectively. The mean annual number of hospitalizations was 1.9 and 2.0 which lasted for a mean of 34.0 and 29.4 days in adults and children, respectively. Twenty-one and forty hospitalization episodes were reported in adults and children, respectively, of which 71.4% and 85.0% were due to catheter-related complications. Mean annual direct costs per patient amounted to 47,857.53 EUR in adults and 74,734.50 EUR in children, with PN and hospitalizations as the main cost-drivers. QoL assessment showed a clinically significant impaired physical component in adults and a notable deterioration in the school functioning domain in children. Conclusion: In Portugal, SBS/CIF patient management is characterized by a substantial therapeutic burden and HRU, translating into high direct costs and a substantial impairment of the adults' physical function and children's school functioning.

Original languageEnglish
Pages (from-to)293-304
Number of pages12
JournalGE Portuguese Journal of Gastroenterology
Volume30
Issue number4
DOIs
Publication statusPublished - 8 Aug 2023
Externally publishedYes

Keywords

  • Chronic intestinal failure
  • Cost of illness analysis
  • Healthcare resource utilization
  • Parenteral nutrition
  • Quality of life
  • Short-bowel syndrome

Fingerprint

Dive into the research topics of 'Clinical, Economic, and Humanistic Impact of Short-Bowel Syndrome/Chronic Intestinal Failure in Portugal (PARENTERAL Study)'. Together they form a unique fingerprint.

Cite this